Emmetrope Ophthalmics, a leader in cell-based therapies for severe eye diseases, today announced the...

Topcon Healthcare has announced an investment in RetiSpec, marking the beginning of a collaboration ...

Aurion Biotech has officially completed the dosing of all participants in its phase 1/2 clinical tri...

Inflammasome Therapeutics has officially dosed the first patient in a pioneering clinical trial aime...

In a significant leadership shift, Topcon Healthcare announced Ali Tafreshi as its new President and...

Naegis Pharmaceuticals Inc., a life sciences company specializing in inflammation and ophthalmology,...

L.V. Prasad Eye Institute (LVPEI) and the Centre for Ocular Research & Education (CORE) at the Unive...

RevOpsis Therapeutics has announced the successful closure of its first seed funding round, securing...

Verana Health has introduced its Qdata Thyroid Eye Disease (TED) module, a new addition to its suite...

LEP Biomedical announced pre-seed funding of €100,000 ($107,000) over two 6-month periods, which the...